Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicarbonate-buffered solution versus Plasma-Lyte during liver transplantation
ACTRN12619001227189Phase 2Completed
- Sponsor
- Professor Rinaldo Bellomo
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of plasma-lyte in hepatic disease (2 arms), sponsored by Professor Rinaldo Bellomo. Primary endpoint: Serum measurement of metabolic acidosis reflected by standard base excess. Started Feb 2021; status: completed.
02
Drugs
plasma-lyte
03
Conditions
hepatic disease
Beyond the preview
Go deeper on ACTRN12619001227189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001227189.